COPENHAGEN LAB ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  2.7% 2.7% 2.7% 2.7% 2.7%  
Bankruptcy risk  7.7% 9.5% 18.7% 16.1% 11.5%  
Credit score (0-100)  33 26 6 11 20  
Credit rating  BB BB B BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  209 0 0 0 0  
Gross profit  31.1 8.7 486 -45.7 -56.8  
EBITDA  31.1 8.7 378 -108 -56.8  
EBIT  31.1 8.7 378 -108 -56.8  
Pre-tax profit (PTP)  32.0 5.3 350.6 -107.9 -56.8  
Net earnings  32.0 5.3 350.6 -107.9 -132.5  
Pre-tax profit without non-rec. items  32.0 5.3 351 -108 -56.8  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -948 -943 -592 -700 -833  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  64.2 21.8 259 57.2 23.1  

Net Debt  -59.2 -16.8 -185 -47.0 -18.1  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  209 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  31.1 8.7 486 -45.7 -56.8  
Gross profit growth  0.0% -72.1% 5,489.9% 0.0% -24.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 -107.6 -62.2 0.0  
Balance sheet total (assets)  64 22 259 57 23  
Balance sheet change%  782.2% -66.0% 1,089.3% -77.9% -59.6%  
Added value  31.1 8.7 485.5 -45.7 -56.8  
Added value %  14.9% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 -2.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  14.9% 0.0% 0.0% 0.0% 0.0%  
EBIT %  14.9% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 77.8% 236.1% 100.0%  
Net Earnings %  15.3% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  15.3% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  15.3% 0.0% 0.0% 0.0% 0.0%  
ROA %  3.2% 0.9% 41.6% -13.4% -7.0%  
ROI %  27.7% 0.0% 0.0% 0.0% 0.0%  
ROE %  89.6% 12.3% 249.5% -68.2% -329.6%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  -93.7% -97.7% -69.5% -92.4% -97.3%  
Relative indebtedness %  484.7% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  456.4% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -190.0% -193.3% -48.9% 43.5% 32.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.1 0.0 0.3 0.1 0.0  
Current Ratio  0.1 0.0 0.3 0.1 0.0  
Cash and cash equivalent  59.2 16.8 184.8 47.0 18.1  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  30.7% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -947.9 -942.6 -592.0 -700.0 -832.7  
Net working capital %  -454.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0